Guy Griebel Selected Research

Guy Griebel Research Topics

Disease

12	Schizophrenia (Dementia Praecox) 10/2016 - 11/2005
6	Anxiety Disorders (Anxiety Disorder) 11/2012 - 04/2002
3	Neurobehavioral Manifestations 10/2016 - 01/2007
2	Memory Disorders (Memory Loss) 01/2018 - 01/2007
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018 - 02/2015
2	Body Weight (Weight, Body) 01/2014 - 04/2002
2	Mental Disorders (Mental Disorder) 05/2012 - 01/2012
2	Depressive Disorder (Melancholia) 01/2012 - 02/2008
2	Cognitive Dysfunction 05/2011 - 05/2011
2	Mood Disorders (Mood Disorder) 05/2011 - 04/2002
2	Ataxia (Dyssynergia) 06/2005 - 01/2003
2	Tobacco Use Disorder (Nicotine Dependence) 06/2005 - 01/2005
1	Alzheimer Disease (Alzheimer's Disease) 12/2019
1	Seizures (Absence Seizure) 01/2015
1	Visceral Pain 01/2015
1	Obesity 01/2014
1	Sleep Wake Disorders 11/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2013
1	Treatment-Resistant Depressive Disorder 01/2013
1	Major Depressive Disorder (Major Depressive Disorders) 11/2012
1	Acute Traumatic Stress Disorders (Acute Stress Disorder) 05/2011
1	Catalepsy 05/2011
1	Weight Gain 05/2011
1	Schizotypal Personality Disorder 01/2009
1	Hypersensitivity (Allergy) 11/2005
1	Dehydration (Water Stress) 01/2005
1	Bites and Stings (Sting) 03/2004
1	Spasm (Spasms) 01/2003
1	Muscle Weakness 01/2003
1	Retinoblastoma (Glioblastoma, Retinal) 04/2002
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2002

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2018 - 01/2003
4	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 11/2012 - 09/2003
4	Vasopressins (Vasopressin)IBA 11/2012 - 04/2002
3	SSR125543IBA 02/2015 - 05/2011
3	Phencyclidine (Angel Dust)IBA 10/2013 - 11/2005
3	Antipsychotic Agents (Antipsychotics)IBA 05/2011 - 01/2009
3	Anti-Anxiety Agents (Anxiolytics)IBA 01/2005 - 01/2003
2	CannabinoidsIBA 01/2018 - 05/2011
2	N-Methylaspartate (NMDA)IBA 10/2016 - 02/2015
2	Serotonin (5 Hydroxytryptamine)IBA 02/2015 - 07/2013
2	TachykininsIBA 01/2015 - 05/2012
2	NeurotensinIBA 01/2015 - 05/2012
2	NeuropeptidesIBA 01/2015 - 11/2003
2	LigandsIBA 01/2015 - 05/2012
2	Neuropeptide Receptors (Neuropeptide Receptor)IBA 01/2015 - 05/2012
2	Corticotropin-Releasing HormoneIBA 05/2012 - 05/2011
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2011 - 06/2005
2	Dopamine (Intropin)FDA LinkGeneric 01/2011 - 01/2010
2	SSR180711IBA 06/2009 - 01/2007
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 06/2009 - 01/2007
2	2- chloro- N- ((S)- phenyl((2S)- piperidin- 2- yl)methyl)- 3- trifluoromethyl benzamideIBA 01/2009 - 11/2005
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2009 - 11/2008
2	6- fluoro- 9- methyl- 2- phenyl- 4- (pyrrolidin- 1- yl- carbonyl)- 2,9- dihydro- 1H- pyrido(3,4- b)indol- 1- oneIBA 06/2005 - 01/2003
2	Nicotine FDA Link 06/2005 - 01/2005
2	Hormones (Hormone)IBA 01/2005 - 04/2002
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2005 - 04/2002
2	4- (2- chloro- 4- methoxy- 5- methylphenyl)- N(2- cyclopropyl- 1- (3- fluoro- 4- methylphenyl)ethyl)- 5- methyl- N- (2- propynyl)- 1,3- thiazol- 2- amineIBA 04/2002 - 04/2002
1	EnzymesIBA 12/2019
1	Glycogen Synthase Kinase 3IBA 12/2019
1	tau Proteins (tau Protein)IBA 12/2019
1	SAR218645IBA 10/2016
1	Glutamic Acid (Glutamate)FDA Link 10/2016
1	metabotropic glutamate receptor 2IBA 10/2016
1	Paroxetine (Paxil)FDA LinkGeneric 02/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2015
1	Cycloserine (Seromycin)FDA Link 02/2015
1	SAR127303IBA 01/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2015
1	Tachykinin Receptors (Tachykinin Receptor)IBA 01/2015
1	CryptochromesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 11/2013
1	tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amideIBA 11/2013
1	Hypnotics and Sedatives (Sedatives)IBA 07/2013
1	Neurokinin-3 ReceptorsIBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	ProlactinIBA 05/2011
1	SR 48968 (saredutant)IBA 05/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2011
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2011
1	Diazepam (Valium)FDA LinkGeneric 05/2011
1	AVE1625IBA 05/2011
1	BenzodiazepinesIBA 05/2011
1	(3- exo)- 8- benzoyl- N- (((2S)7- chloro- 2,3- dihydro- 1,4- benzodioxin- 1- yl)methyl)- 8- azabicyclo(3.2.1)octane- 3- methanamine monohydrochlorideIBA 01/2011
1	Dizocilpine Maleate (Dizocilpine)IBA 06/2009
1	Amphetamine (Amfetamine)FDA LinkGeneric 06/2009
1	Nitroarginine (NG Nitro L Arginine)IBA 06/2009
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2008
1	ST 679IBA 11/2005
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 11/2005
1	EndocannabinoidsIBA 06/2005
1	SmokeIBA 06/2005
1	RimonabantIBA 06/2005
1	CRF receptor type 1IBA 03/2004
1	Antidepressive Agents (Antidepressants)IBA 09/2003
1	GABA-A Receptor AgonistsIBA 01/2003

Therapy/Procedure

2	Therapeutics 01/2014 - 05/2012
1	Deep Brain Stimulation 01/2013
1	Drug Therapy (Chemotherapy) 11/2003